Profound Medical (PROF) Profit After Tax Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | 34.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.23% |
| Dec 31, 2025 | -65.25% |
| Sep 30, 2025 | 14.82% |
| Jun 30, 2025 | -126.84% |
| Mar 31, 2025 | -56.35% |
| Dec 31, 2024 | 42.90% |
| Sep 30, 2024 | -667.92% |
| Jun 30, 2024 | -160.31% |
| Mar 31, 2024 | -201.75% |
| Dec 31, 2023 | 81.88% |
| Sep 30, 2023 | -67.00% |
| Jun 30, 2023 | -48.69% |
| Mar 31, 2023 | 182.06% |
| Dec 31, 2022 | 6.69% |
| Sep 30, 2022 | 141.99% |
| Jun 30, 2022 | 149.22% |
| Mar 31, 2022 | -196.83% |
| Dec 31, 2021 | -136.97% |
| Sep 30, 2021 | -66.66% |
| Jun 30, 2021 | -3.54% |
| Mar 31, 2021 | 416.21% |
| Dec 31, 2020 | -209.69% |
| Sep 30, 2020 | 30.39% |
| Jun 30, 2020 | 112.94% |
| Mar 31, 2020 | -223.88% |
| Dec 31, 2019 | 170.96% |